Teva Pharmaceutical Industries Limited stock is up 15.2% since 30 days ago. The next earnings date is Feb 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.71% of the previous 33 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 2 CALLs, 8 PUTs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
27 Nov 15:10 | 19 Jan, 2024 | 5.00 | 1774 | ||
27 Nov 16:23 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 16:44 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 16:46 | 19 Jan, 2024 | 10.00 | 17500 | ||
27 Nov 16:46 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 17:09 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 17:10 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 17:11 | 17 Jan, 2025 | 12.00 | 2262 | ||
27 Nov 17:13 | 17 Jan, 2025 | 12.00 | 2262 | ||
28 Nov 15:14 | 17 Jan, 2025 | 7.00 | 2844 |
Teva Pharmaceutical Industries Limited sells generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Its products in the central nervous system, pain, respiratory, and oncology areas include Copaxone for the treatment of relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.